Financing channel feed – Endpoints News

Financing channel feed

BioNTech-backed ADC maker DualityBio plans IPO on Hong Kong exchange

4 weeks ago

Exclusive: Cardiometabolic biotech gets $57.5M Series B, with help from Cytokinetics

5 weeks ago

Market turmoil is tanking biotech M&A and IPOs. Here's the playbook startups will use to survive

Last month

Exclusive: Merida Biosciences gets $121M to treat autoimmune and allergy diseases at their roots

Last month

Stock market melts down over Trump’s tariffs, and biotech's pain keeps growing

Last month

Immunology startup RayThera secures $110M in Series A raise

Last month

ADC startup DualityBio seeks Hong Kong IPO amid precarious market

Last month

PIPEs, biopharma’s favorite financing vehicle, freeze amid market struggles

Last month

Exclusive: Daymark Health launches with $11.5M to care for cancer patients

Last month

Exclusive: Neurona bags $102M to treat epilepsy with cell therapy

Last month

Atsena gets Bain's support in $150M Series C to thwart blindness with gene therapy

Last month

RNA editing startup raises $155M to bring liver and lung disease therapy into clinic

Last month

Alphabet’s Isomorphic Labs raises $600M in biotech’s largest round of 2025

Last month

Exclusive: SV Health debuts Parkinson's biotech with backing from AbbVie and others

Last month

Galatea Bio gets $25M to map genetic diversity of 10 million people, help pharma create new medicines

Last month

Ophthalmology startup Character Biosciences gets $93M for genetics-based approach

Last month

Another immunology biotech emerges as Hillstar takes flight with $67M

Last month

Tempero Bio, led by ex-Novartis execs, gets $70M to reduce substance use disorders

Last month

23andMe files for bankruptcy, CEO Wojcicki steps down

Last month

Belgian biotech Augustine gets $85M for neuro and cardiometabolic pills

Last month

SV Health Investors nabs $250M to fund dementia-focused biotechs

Last month

Ascendis’ China joint venture, Visen Pharmaceuticals, prices $86M Hong Kong IPO

Last month

Flagship's Ampersand gets Eli Lilly's support in $65M Series B

Last month

A Japanese biotech founded by Treg cell discoverer moves to the US with $45.8M

Last month

First page Previous page 123 4 5 Next page Last page